ENTITY

CSL (CSL AT)

2
Analysis
Health Care • United States
CSL Limited develops, manufactures, and markets human pharmaceutical and diagnostic products derived from human plasma. The Company provides products include pediatric and adult vaccines, infection, pain medicine, skin disorder remedies, antivenoms, anticoagulants, and immunoglobulins.
more
•12 Dec 2017 12:43

Putting Aussie Earnings Under the Microscope

It's not too late to jump on board the Growth train. One of our key calls for 2018 is that Growth will again outperform Value (Aussie Equities...

Logo
296 Views
Share
•05 Dec 2017 14:26

Aussie Healthcare Daily: 5 Dec 2017

The Aussie Healthcare Daily is a summary of major news and announcements from ASX-listed healthcare companies as well as developments and trends in...

Logo
288 Views
Share
•02 Dec 2017 15:18

Aussie Healthcare Daily: 1 Dec 2017

The Aussie Healthcare Daily is a summary of major news and announcements from ASX-listed healthcare & biotech companies as well as developments...

Logo
345 Views
Share
•04 May 2026 11:00

MS-Australia Index Earning Revision (Apr): Lynas Rare Earths, National Australia Bank, BHP, Westpac

We analyzed MS-Australia's consensus for Apr 2026 and highlighted changes of EPS in Lynas Rare Earths, National Australia Bank, BHP, Westpac,...

Logo
283 Views
Share
bullish•Blackmores Ltd
•11 Oct 2017 12:39

Equity Asia Weekly Research - 11 Oct 2017

Mid Term Country Allocation (Tactical view) in terms of Relative Value vs MXAPWhat's new from last week• Although ASX remains within its 3-month...

Logo
431 Views
Share
x